Long-Term Survival and Quality of Life Assessment After Allogeneic Stem-Cell Transplantation; Comparable Results Following Myeloablative and Reduced-Intensity Conditioning

被引：0
|
作者：
Shimoni, Avichai [1 ]
Tallis, Eran [1 ]
Shem-Tov, Noga [1 ]
Volchek, Yulia [1 ]
Yerushalmi, Ronit [1 ]
Nagler, Arnon [1 ,2 ]
机构：
[1] Chaim Sheba Med Ctr, Div Hematol, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Univ, Guy Weinshtock Multiple Myeloma Fdn, Tel Hashomer, Israel
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1749 / 1749
页数：1
相关论文
共 50 条
  • [1] Long-term survival and quality of life assessment after allogeneic stem cell transplantation for haematological malignancies; comparable results following myeloablative and reduced-intensity conditioning
    Shimoni, A.
    Tallis, E.
    Shem-Tov, N.
    Volchek, Y.
    Yerushalmi, R.
    Nagler, A.
    [J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S51 - S52
  • [2] LONG-TERM SURVIVAL AND QUALITY OF LIFE (QOL) ASSESSMENT AFTER ALLOGENEIC STEM-CELL TRANSPLANTATION (SCT) FOR ACUTE LEUKEMIA AND MDS; COMPARABLE RESULTS WITH MYELOABLATIVE AND REDUCED-INTENSITY CONDITIONING
    Shimoni, A.
    Talus, E.
    Rand, A.
    Shem-Tov, N.
    Volchek, Y.
    Yerushalmi, R.
    Nagler, A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S177 - S177
  • [3] Long-Term Survival and Late Events After Allogeneic Stem-Cell Transplantation with Reduced-Intensity Conditioning (RIC) for AML and Mds; Comparable Results with Myeloablative Conditioning
    Shimoni, Avichai
    Rand, Avitat
    Shem-Tov, Noga
    Hardan, Izhar
    Volchek, Yulia
    Maayaan, Hannah
    Yerushalmi, Ronit
    Nagler, Arnon
    [J]. BLOOD, 2009, 114 (22) : 214 - 215
  • [4] Long-term survival and late events after allogeneic stem cell transplantation for acute leukaemia and MDS: comparable results with myeloablative and reduced-intensity conditioning
    Shimoni, A.
    Rand, A.
    Shem-Tov, N.
    Hardan, I.
    Volchek, Y.
    Maayaan, H.
    Yerushalmi, R.
    Nagler, A.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S59 - S59
  • [5] Long-term complications and quality of life after reduced-intensity conditioning allogeneic stem cell transplantation
    Clavert, A.
    Peric, Z.
    Cahu, X.
    Chevallier, P.
    Brissot, E.
    Malard, F.
    Guillaume, T.
    Delaunay, J.
    Ayari, S.
    Dubruille, V.
    Le Gouill, S.
    Mahe, B.
    Gastinne, T.
    Blin, N.
    Harousseau, J-L.
    Moreau, P.
    Milpied, N.
    Mohty, M.
    [J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S52 - S52
  • [6] LONG-TERM SURVIVAL AND QUALITY OF LIFE (QoL) ASSESSMENT AFTER REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM-CELL TRANSPLANTATION (SCT) FOR HEMATOLOGICAL MALIGNANCIES
    Shimoni, A.
    Tallis, E.
    Shem-Tov, N.
    Volchek, Y.
    Yerushalmi, R.
    Nagler, A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S227 - S227
  • [7] Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma
    El-Cheikh, Jean
    Crocchiolo, Roberto
    Furst, Sabine
    Stoppa, Anne-Marie
    Ladaique, Patrick
    Faucher, Catherine
    Calmels, Boris
    Lemarie, Claude
    De Colella, Jean-Marc Schiano
    Granata, Angela
    Coso, Diane
    Bouabdallah, Reda
    Chabannon, Christian
    Blaise, Didier
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (05) : 370 - 374
  • [8] LONG-TERM OUTCOME (BEYOND 10 YEARS) AFTER ALLOGENEIC STEM-CELL TRANSPLANTATION WITH REDUCED-INTENSITY COMPARED TO MYELOABLATIVE CONDITIONING; SIMILAR SURVIVAL BUT DIFFERENT PATTERN OF LATE EVENTS
    Shimoni, A.
    Yerushalmi, R.
    Shem-Tov, N.
    Volchek, Y.
    Nagler, A.
    [J]. HAEMATOLOGICA, 2013, 98 : 371 - 371
  • [9] Long-term results of allogeneic stem cell transplantation after reduced-intensity conditioning regimen fludarabin, busulfan and ATG
    Brychtova, Y.
    Krejci, M.
    Muzik, J.
    Doubek, M.
    Mayer, J.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S294 - S294
  • [10] Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up
    Shimoni, A.
    Hardan, I.
    Shem-Tov, N.
    Yerushalmi, R.
    Nagler, A.
    [J]. LEUKEMIA, 2010, 24 (05) : 1050 - 1052
12345